- Rx3000® UV-C Light, HEPA filtration combination inactivates and traps 99.9% of airborne viruses, bacteria, mold, fungi and particulates
- RX3000 is a “Made in the USA” FDA Cleared Class II medical device ideal for healthcare facilities, schools, offices, manufacturing facilities, government buildings and beauty salons
|
“Thanks to Strategic Links’ robust supplier and manufacturing partner network and perseverance, we have been able to complete assembly and testing of the Rx3000 units ‘Made in the USA’ despite the COVID-related supply chains disruptions,” stated
“With the Rx3000 from
“Scott Electronics and Strategic Link collaborated to help bring a better product to market in a very short period of time under difficult circumstances,” stated
Continual Improvement
“Strategic Link and its manufacturing partner
Since The
Rx3000’s FDA clearance as a Class II Medical Device allows for its use in hospitals and other healthcare facilities to reduce the risk of airborne disinfection.
“Continuous effective air disinfection in addition to following hygiene protocols and surface disinfection is critical because microscopic aerosolized viruses and bacteria expelled when people talk, breath, cough and sneeze will contaminate any disinfected room instantly,” stated Dr.
“The major advantage of Rx3000 is that it continually swirls air past powerful germicidal UV-C lights for a high intensity dose that inactivates or kills more than 99.9% of airborne viruses, bacteria, mold and fungi and it traps those pathogens, plus airborne particulates, to reduce risk of infection and irritation,” Stone added. “Rx3000’s patented UV light ‘kill chamber’ makes it safer for users during HEPA filter changes as the viruses and bacteria caught in the filter are inactive or dead and unable to cause infection, versus active or live viruses and bacteria that may become dislodged and inhaled when changing filters in traditional air purifiers.”
Testing in EPA-certified laboratories shows Rx3000 has been proven effective against harmful pathogens including multiple coronaviruses, H1N1, MRSA, pneumonia, strep, TB, measles, influenza, and the common cold and also neutralizes odors, indoor pollutants, and VOCs (volatile organic compounds) 1, 2, 3, 4, 5, 6. Each portable RxAir unit provides four to eight complete air changes per hour (ACH) for a 1500 to 3000 sq. ft. room to minimize risk of infection from airborne diseases for all in the room.
RxAir will begin taking deposits on Rx3000 pre-orders beginning
For information on how to become an RxAir/Rx3000 distributor and/or bulk pricing, contact
Lee Howley, lhowley@vytex.com
Follow
Twitter: @VystarCompany
#RxAir , #Coronavirus, #Covid, #UVLight, #UVdisinfection
Sources:
- Kowalski, (2013, June) Residential Application of the RxAir UV light Portable Air Purification Unit, https://www.rxair.com/lab_results/residential-application/
- Kowalski, (2009,
Dec. 1 ) Prediction of Virus Inactivation by the UV 400, https://www.rxair.com/lab_results/virus-inactivation/ - Kowalski, (2012, Jan20) Supplemental Air Purification for Hospitals and Health Care Facilities, https://www.rxair.com/lab_results/health-care-facilities/
- Kowalski, Walsh, Petraitis (2020, March) 2020 COVID-19 Coronavirus Ultraviolet Susceptibility, https://www.researchgate.net/publication/339887436_2020_COVID-19_Coronavirus_Ultraviolet_Susceptibility, Accessed
October 10, 2020 - Coffey, Donavyn, Does UV light kill the new coronavirus?, (
July 12, 2020 ) Live Science, https://www.livescience.com/uv-light-kill-coronavirus.html, (AccessedJuly 14, 2020 ) Centers for Disease Control (2020,April 29 ) Decontamination & Reuse of Filtering Facepiece Respirators. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html. (AccessedJuly 21, 2020 )Centers for Disease Control (October 5, 2020 ) How Covid-19 Spreads: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html (AccessedOct 9, 2020 )- Prather K., Marr L., Schooley R. et al., Airborne transmission of SARS-CoV-2, Science,
Oct. 5, 2020 doi: 10.1126/science.abf052,
https://science.sciencemag.org/content/early/2020/10/02/science.abf0521/tab-pdf (AccessedOct. 9, 2020 )
Financial Disclosure: Dr.
# # #
About
About
Based in
Contacts:
Media:
Investors: Lee Howley, lhowley@vytex.com 508-791-9114
Distributor Opportunities:
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
Attachments
Vystar Corp Vystar Corp Vystar Corp
Source:
2020 GlobeNewswire, Inc., source